Citigroup
RPRX

Citigroup’s Repros Therapeutics Inc. RPRX Stock Holding History

Citigroup’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-985
Closed -$1K – 7759
2017
Q1 		$1K Hold
985
– – ﹤0.01% 7163
2016
Q4 		$1K Hold
985
– – ﹤0.01% 7163
2016
Q3 		$2K Hold
985
– – ﹤0.01% 6963
2016
Q2 		$2K Sell
985
-25
-2% -$48 ﹤0.01% 6962
2016
Q1 		$1K Sell
1,010
-245
-20% -$239 ﹤0.01% 7413
2015
Q4 		$1K Buy
1,255
+95
+8% +$305 ﹤0.01% 7507
2015
Q3 		$9K Sell
1,160
-4,575
-80% -$35K ﹤0.01% 6526
2015
Q2 		$41K Sell
5,735
-2,133
-27% -$16.6K ﹤0.01% 5673
2015
Q1 		$68K Sell
7,868
-1,099
-12% -$9.83K ﹤0.01% 5319
2014
Q4 		$90K Buy
8,967
+2,924
+48% +$24.9K ﹤0.01% 5323
2014
Q3 		$59K Sell
6,043
-46,250
-88% -$685K ﹤0.01% 5188
2014
Q2 		$904K Sell
52,293
-6,858
-12% -$112K ﹤0.01% 3049
2014
Q1 		$1.05M Buy
59,151
+2,120
+4% +$41K ﹤0.01% 2841
2013
Q4 		$1.04M Buy
57,031
+56,955
+74,941% +$1.08M ﹤0.01% 3136
2013
Q3 		$2K Sell
76
-40,943
-100% -$877K ﹤0.01% 6645
2013
Q2 		$757K Buy
+41,019
New +$724K ﹤0.01% 3131

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
AIA
Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citigroup's RPRX Position: Q2 2017 in Review

Citigroup sold out of Repros Therapeutics Inc. (RPRX) in Q2 2017, closing a stake of 985 shares — an estimated $1K sold.

Citigroup first reported a position in RPRX in Q2 2013 and held it in 16 quarters. The position peaked at $1.05M in Q1 2014. 29 funds tracked by Wall St. Rank hold RPRX as of Q2 2017.

  • Citigroup reported no remaining Repros Therapeutics Inc. position as of Q2 2017 after selling out during the quarter.
  • Citigroup sold 985 Repros Therapeutics Inc. shares in Q2 2017, an estimated $1K.
  • Citigroup first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 16 quarters.
  • Citigroup's Repros Therapeutics Inc. position peaked at $1.05M in Q1 2014.
  • 29 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q2 2017.

Based on Citigroup's 13F filing for Q2 2017, filed 11 Aug 2017.